Dataciencia

Colección SciELO Chile

Phase III Trial of Ipilimumab Combined With Paclitaxel and Carboplatin in Advanced Squamous Non-Small-Cell Lung Cancer

Indexado

WoS	WOS:000413081500012
Scopus	SCOPUS_ID:85032431445

DOI

10.1200/JCO.2016.71.7629

Año

2017

Tipo

artículo de investigación

Citas Totales

Autores Afiliación Chile

Instituciones Chile

% Participación
Internacional

Autores
Afiliación Extranjera

Instituciones
Extranjeras

Abstract

The addition of ipilimumab to first-line chemotherapy did not prolong OS compared with chemotherapy alone in patients with advanced squamous NSCLC. The safety profile of chemotherapy plus ipilimumab was consistent with that observed in previous lung and melanoma studies. Ongoing studies are evaluating ipilimumab in combination with nivolumab in this population. (C) 2017 by American Society of Clinical Oncology

Revista

Revista	ISSN
Journal Of Clinical Oncology	0732-183X

Métricas Externas

PlumX	Altmetric	Dimensions

Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:

Plumx: https://plumanalytics.com/learn/about-metrics/
Altmetric: https://www.altmetric.com/about-altmetrics/what-are-altmetrics/
Dimensions: https://www.dimensions.ai/why-dimensions/

Disciplinas de Investigación

WOS
Oncology

Scopus
Oncology
Cancer Research

SciELO
Sin Disciplinas

Muestra la distribución de disciplinas para esta publicación.

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.

Colaboración Institucional

Muestra la distribución de colaboración, tanto nacional como extranjera, generada en esta publicación.

Autores - Afiliación

Ord.	Autor	Género	Institución - País
1	Govindan, Ramaswamy	-	WASHINGTON UNIV - Estados Unidos Washington University School of Medicine in St. Louis - Estados Unidos
2	Szczesna, Aleksandra	Mujer	Mazowieckie Ctr Leczenia Chorob Pluc & Gruzlicy - Polonia Mazowieckie Centrum Leczenia Chorób Płuc i Gruźlicy - Polonia
3	Ahn, Myung Ju	-	Sungkyunkwan Univ - Corea del Sur Sungkyunkwan University - Corea del Sur
4	Schneider, Claus-Peter	Hombre	Zentralklin Bad Berka - Alemania Zentralklinik Bad Berka - Alemania
5	Mella, Pablo	Hombre	Universidad de Valparaíso - Chile Fdn Arturo Lopez Perez - Chile
5	Mella, Pablo Fernando Gonzalez	Hombre	Universidad de Valparaíso - Chile Fdn Arturo Lopez Perez - Chile
6	Barlesi, F.	Hombre	Aix Marseille Univ - Francia Aix Marseille Université - Francia
7	Han, Baohui	-	Shanghai Jiao Tong Univ - China Shanghai Chest Hospital - China
8	Ganea, Doina Elena	Mujer	Spitalul Judetean Urgenta Suceava - Rumania Spitalul Judetean De Urgenta Suceava - Rumania
9	Pawel, Joachim Von	Hombre	Asklepius Fachkliniken - Alemania
9	Von Pawel, Joachim	Hombre	Asklepius Fachkliniken - Alemania
10	Vladimirov, Vladimir	Hombre	Pyatigorsk Oncol Dispensary - Rusia State Healthcare Institute - Rusia
11	Fadeeva, Natalia	Mujer	Chelyabinsk Reg Oncol Dispensary - Rusia Chelyabinsk Regional Clinical Oncology Dispensary - Rusia
12	Lee, Ki Hyeong	-	Chungbuk Natl Univ Hosp - Corea del Sur Chungbuk National University Hospital - Corea del Sur
13	Kurata, Takayasu	Hombre	Kansai Med Univ - Japón Kansai Medical University - Japón Kansai Medical University Hospital - Japón
14	Zhang, Li	-	Sun Yat Sen Univ - China Sun Yat-Sen University Cancer Center - China
15	Tamura, Tomohide	-	St Lukes Int Hosp - Japón St. Luke's International Hospital Tokyo - Japón
16	Postmus, Pieter E.	Hombre	UNIV LIVERPOOL - Reino Unido University of Liverpool - Reino Unido
17	Jassem, Jacek	Hombre	Med Univ Gdansk - Polonia Gdanski Uniwersytet Medyczny - Polonia
18	O'Byrne, Kenneth	Hombre	Princess Alexandra Hosp - Australia Queensland Univ Technol - Australia Queensland University of Technology QUT - Australia Queensland University of Technology - Australia
19	Kopit, Justin	Hombre	Bristol Myers Squibb - Estados Unidos Bristol-Myers Squibb - Estados Unidos
20	Li, Mingshun	-	Bristol Myers Squibb - Estados Unidos Bristol-Myers Squibb - Estados Unidos
21	Tschaika, Marina	Mujer	Bristol Myers Squibb - Estados Unidos Bristol-Myers Squibb - Estados Unidos
22	Reck, Martin	Hombre	German Ctr Lung Res - Alemania German Center for Lung Research - Alemania

Muestra la afiliación y género (detectado) para los co-autores de la publicación.

Financiamiento

Fuente
European Commission
Bristol-Myers Squibb
Pfizer
AstraZeneca
Eli Lilly
MethylGene (Inst)
GlaxoSmithKline (Inst)
Abbvie (Inst)
Bayer (Inst)
MSD Oncology
Chugai Pharma
US Code of Federal Regulations

Muestra la fuente de financiamiento declarada en la publicación.

Agradecimientos

Agradecimiento
Bristol-Myers Squibb, Pfizer, Eli Lilly
The protocol was approved by each participating center’s ethics committee or institutional review board. The study was run in accordance with Good Clinical Practice (defined by the International Conference on Harmonization) and the ethical principles underlying European Union Directive 2001/20/EC and the US Code of Federal Regulations, Title 21, Part 50 (21CFR50). All patients provided written, informed consent to their participation in the study. An independent data monitoring committee provided study oversight.

Agradecimiento

Bristol-Myers Squibb, Pfizer, Eli Lilly

The protocol was approved by each participating center’s ethics committee or institutional review board. The study was run in accordance with Good Clinical Practice (defined by the International Conference on Harmonization) and the ethical principles underlying European Union Directive 2001/20/EC and the US Code of Federal Regulations, Title 21, Part 50 (21CFR50). All patients provided written, informed consent to their participation in the study. An independent data monitoring committee provided study oversight.